Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETSPA: Adalimumab and DMARDs for Axial and Aortic Inflammation in axSpA
NCT02634541Phase 4Unknown
- Sponsor
- University of Helsinki
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in ankylosing spondylitis (AS), sponsored by University of Helsinki. Status: unknown.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02634541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634541.